CellProthera

About:

CellProthera is a medical biotech company based in Mulhouse, France.

Website: https://www.cellprothera.com/

Twitter/X: cellprothera

Top Investors: Alsace Business Angels

Description:

CellProthera is the first company having conducted successful proof of principle study with autologous CD34+ stem cells to repair myocardial tissue after acute myocardial infarct (AMI). The clinical outcome indicated an excellent safety profile associated with outstanding clinical benefits. The innovative approach developed by CellProthera is viewed by experts as one of the most effective to treat AMI and prevent secondary congestive heart failure (CHF).